Ruane, P. J., Shiha, G., Abergel, A., Asselah, T., Kohli, A., Kottilil, S., … Knox, S. (2016). 756 Integrated Analysis of Sof+RBV or LDV/Sof for the Treatment of Genotype 4 Chronic HCV Infection. In Gastroenterology (Vol. 150, pp. S1047–S1048). Elsevier BV. https://doi.org/10.1016/s0016-5085(16)33541-7

Ruane, Peter J., Gamal Shiha, Armand Abergel, Tarik Asselah, Anita Kohli, Shyam Kottilil, Susanna Naggie, et al. “756 Integrated Analysis of Sof+RBV or LDV/Sof for the Treatment of Genotype 4 Chronic HCV Infection.” In Gastroenterology, 150:S1047–48. Elsevier BV, 2016. https://doi.org/10.1016/s0016-5085(16)33541-7.

Ruane PJ, Shiha G, Abergel A, Asselah T, Kohli A, Kottilil S, et al. 756 Integrated Analysis of Sof+RBV or LDV/Sof for the Treatment of Genotype 4 Chronic HCV Infection. In: Gastroenterology. Elsevier BV; 2016. p. S1047–8.

Ruane, Peter J., et al. “756 Integrated Analysis of Sof+RBV or LDV/Sof for the Treatment of Genotype 4 Chronic HCV Infection.” Gastroenterology, vol. 150, no. 4, Elsevier BV, 2016, pp. S1047–48. Crossref, doi:10.1016/s0016-5085(16)33541-7.

Ruane PJ, Shiha G, Abergel A, Asselah T, Kohli A, Kottilil S, Naggie S, Doss W, Esmat G, Letterio CM, Hahambis TA, Natha M, Kreter B, Kersey K, Brainard D, Knox S. 756 Integrated Analysis of Sof+RBV or LDV/Sof for the Treatment of Genotype 4 Chronic HCV Infection. Gastroenterology. Elsevier BV; 2016. p. S1047–S1048.